Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 5

Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients

Authors Hanne H Villesen, Anne-Marie Banning, Rasmus H Petersen, Sebatian Weinelt, Jesper B Poulsen, et al

Published 15 November 2007 Volume 2007:3(5) Pages 961—967

Hanne H Villesen1, Anne-Marie Banning2, Rasmus H Petersen3, Sebatian Weinelt3, Jesper B Poulsen3, Steen H Hansen4, Lona L Christrup1
1Department of Pharmacology and Pharmacotherapy, The Danish University of Pharmaceutical Sciences, Copenhagen, Denmark; 2Department  of Anesthesiology, Gentofte University Hospital, Copenhagen, Denmark; 3Department of Anesthesiology, Esbjerg Hospital, Esbjerg, Denmark;4Department of Pharmaceutics and Analytical Chemistry, The Danish University of Pharmaceutical Sciences, Copenhagen, Denmark

Background: An increased and prolonged duration of pain relief after morphine administration has been found in elderly patients. Whether this is due to alterations in pharmacokinetics, receptor binding profile or other factors remains unsolved. The aims were to elucidate the pharmacokinetics after intravenous administration of morphine and oxycodone in elderly patients older than 70 years.

Methods: A randomized non-blinded study with 16 patients aged older than 70 years scheduled for elective hip replacement receiving morphine or oxycodone 0.05 mg/kg as an IV infusion over 15 minutes.

Results: A 2-compartment pharmacokinetic model best described the disposition of morphine and oxycodone. The estimated elimination half-lives for morphine and oxycodone were (mean ± SD) 2.7 ± 3.6 (range 0.8–11.6) and 3.1 ± 1.3 (range 1.1–4.8) hr, respectively. Volume of distribution at steady state was estimated to be 243 ± 256 and 277 ± 187 L, and clearance to be 1748 ± 623 and 1206 ± 546 ml/min for morphine and oxycodone, respectively.

Conclusion: The increased and prolonged duration of pain relief after morphine administration seen in some elderly patients cannot, based on these findings, be ascribed to changes in the pharmacokinetic parameters between elderly and younger patients. Similar for oxycodone, no changes in the pharmacokinetic could be found when comparing the parameters found in elderly patients with those from younger healthy volunteers. A great variability within the individual pharmacokinetic parameters was seen for both drugs. Therefore, we recommend that treatment with morphine and oxycodone in elderly patients is initiated very conservatively and is titrated slowly to effect.

Keywords: morphine, oxycodone, pharmacokinetics, age, elderly

A Letter to the Editor has been received and published for this article.

Download Article [PDF] 

Readers of this article also read:

USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study

Frankova S, Jirsa M, Merta D, Neroldova M, Urbanek P, Senkerikova R, Spicak J, Sperl J

Therapeutics and Clinical Risk Management 2015, 11:1853-1861

Published Date: 17 December 2015

Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal cancer: a meta-analysis

Yang X, Huang Y, Feng JF, Liu JS

OncoTargets and Therapy 2015, 8:789-794

Published Date: 10 April 2015

Detection of PLGA-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopy

Pascolo L, Bortot B, Benseny-Cases N, Gianoncelli A, Tosi G, Ruozi B, Rizzardi C, De Martino E, Vandelli MA, Severini GM

International Journal of Nanomedicine 2014, 9:2791-2801

Published Date: 7 June 2014

In situ precipitation: a novel approach for preparation of iron-oxide magnetoliposomes

Xia S, Li P, Chen Q, Armah M, Ying X, Wu J, Lai J

International Journal of Nanomedicine 2014, 9:2607-2617

Published Date: 23 May 2014

Polymersomes containing quantum dots for cellular imaging

Camblin M, Detampel P, Kettiger H, Wu D, Balasubramanian V, Huwyler J

International Journal of Nanomedicine 2014, 9:2287-2298

Published Date: 12 May 2014

Hypoxia attenuates purinergic P2X receptor-induced inflammatory gene expression in brainstem microglia

Smith SMC, Mitchell GS, Friedle SA, Sibigtroth CM, Vinit S, Watters JJ

Hypoxia 2013, 1:1-11

Published Date: 6 August 2013

Non-ionic surfactant vesicles simultaneously enhance antitumor activity and reduce the toxicity of cantharidin

Han W, Wang S, Liang R, Wang L, Chen M, Li H, Wang Y

International Journal of Nanomedicine 2013, 8:2187-2196

Published Date: 14 June 2013

Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm

Hernandez-Delgadillo R, Velasco-Arias D, Diaz D, Arevalo-Niño K, Garza-Enriquez M, De la Garza-Ramos MA, Cabral-Romero C

International Journal of Nanomedicine 2012, 7:2109-2113

Published Date: 24 April 2012